Total Voting Rights

Summary by AI BETAClose X

Dr. Martens plc has announced its total voting rights as of November 28, 2025, stating that its issued ordinary share capital comprises 967,082,030 ordinary shares, each with one voting right, and that no shares are held in treasury. This figure of 967,082,030 represents the total number of shares with voting rights and will serve as the denominator for shareholders calculating their notification obligations under the FCA's Disclosure Guidance and Transparency Rules.

Disclaimer*

Dr. Martens PLC
28 November 2025
 

Dr. Martens plc (the "Company")

 

Total Voting Rights

 

The following information is released in accordance with the FCA's Disclosure Guidance and Transparency Rule 5.6.1.

 

As at the date of this disclosure, the Company's issued ordinary share capital consists of 967,082,030 ordinary shares of GBP 0.01 each, each carrying one voting right. The Company does not hold any shares in Treasury. Therefore, the total number of shares with voting rights in the Company is 967,082,030.

 

The above figure (967,082,030) can be used by shareholders as the denominator for the calculations by which to determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules. 

 

For further information please contact:

 

Rebecca Flaherty

Assistant Company Secretary

Dr. Martens plc

+447853982165

                                                                                                                      

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 

Companies

Dr. Martens (DOCS)
UK 100

Latest directors dealings